Right To Try Act Poses Big Challenge For FDA
(By Michael D. Becker for NPR) In his first year as commissioner of the Food and Drug Administration, Scott Gottlieb
Read More
FDA
Drugmakers Blamed For Blocking Generics Have Jacked Up Prices And Cost U.S. Billions
(By Sydney Lupkin for Kaiser Health News) Makers of brand-name drugs called out by the Trump administration for potentially stalling
Read MoreFDA plans to speed path to approval for some gene therapies, starting with hemophilia
(By Ike Swetlitz for STAT) WASHINGTON — The Food and Drug Administration will soon be alerting companies that certain gene
Read MoreFDA’s strategic priorities for 2018 is advancing digital health technologies
One of the priorities this year for the FDA is advancing digital health technologies. FDA’s Center for Devices and Radiological
Read MoreNew Type Of Drug To Prevent Migraines Heads To Market
(By Richard Harris for NPR) The Food Drug Administration has approved a first-of-its-kind drug that reduces the number of migraines
Read MoreRight-to-try bill headed for vote puts bigger burden on FDA to protect patients, Gottlieb says
(By Ike Swetlitz and Erin Mershon for STAT) WHITE OAK, Md. — The House is set to take up a
Read MoreFDA calls out 39 drug companies for allegedly blocking access to generics
(By Erin Mershon for STAT) Johnson & Johnson’s Actelion Pharmaceuticals, Celgene, and Gilead Life Sciences are all potentially blocking generic
Read MoreHow A Drugmaker Gamed The System To Keep Generic Competition Away
(By Alison Kodjak for NPR) When Celgene Corp. first started marketing the drug Revlimid to treat multiple myeloma in 2006,
Read MoreIn a first, FDA approves drug meant to mitigate symptoms of opioid withdrawal
(By Lev Facher for STAT) WASHINGTON — The Food and Drug Administration on Wednesday approved for the first time a
Read MoreFederal kickback law might be used to bring down drug prices, FDA commissioner suggests
(By Ike Swetlitz for STAT) WASHINGTON — The commissioner of the Food and Drug Administration, Scott Gottlieb, on Thursday suggested
Read More